Johannes Herta

Dr. Johannes Herta

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2017 in Clinical Neurophysiology
Verified
Journal Article
Closed access
JHJohannes Herta
Johannes Herta
JKJohannes Koren
Johannes Koren
FFF. Fürbass
F. Fürbass
MHM. Hartmann
M. Hartmann
AGA. Gruber
A. Gruber
CBC. Baumgartner
C. Baumgartner

1 August 2015 in Epilepsy & Behavior
Verified
Journal Article
Closed access
JHJohannes Herta
Johannes Herta
JKJohannes Koren
Johannes Koren
FFF. Fürbass
F. Fürbass
MHM. Hartmann
M. Hartmann
TKT. Kluge
T. Kluge
AGA. Gruber
A. Gruber

1 September 2015 in Neurophysiologie Clinique
Verified
Journal Article
Closed access
FFF. Fürbass
F. Fürbass
MHM.M. Hartmann
M.M. Hartmann
JHJ.J. Halford
J.J. Halford
JKJohannes Koren
Johannes Koren
JHJohannes Herta
Johannes Herta
TKT. Kluge
T. Kluge

1 February 2016 in Clinical Neurophysiology
Verified
Journal Article
Closed access
JKJohannes Koren
Johannes Koren
JHJohannes Herta
Johannes Herta
SPSusanne Pirker
Susanne Pirker
FFFranz Fürbass
Franz Fürbass
MHManfred Hartmann
Manfred Hartmann
CBChristoph Baumgartner
Christoph Baumgartner

1 August 2015 in Epilepsy & Behavior
Verified
Journal Article
Closed access
JKJohannes Koren
Johannes Koren
JHJohannes Herta
Johannes Herta
SDS. Draschtak
S. Draschtak
GPG. Pötzl
G. Pötzl
SPS. Pirker
S. Pirker
CBC. Baumgartner
C. Baumgartner

8 November 2021 in Frontiers in Neurology
Verified
Journal Article
Open access
FKFarjad Khalaveh
Farjad Khalaveh
NFNadia Fazel
Nadia Fazel
MMMario Mischkulnig
Mario Mischkulnig
MVMatthias Gerhard Vossen
Matthias Gerhard Vossen
ARAndrea Reinprecht
Andrea Reinprecht
JHJohannes Herta
Johannes Herta
Objectives: Multiple risk factors have been described to be related to external ventricular drain (EVD) associated infections, with results varying between studies. Former studies were limited by a non-uniform definition of EVD associated infection, thus complicating a comparison between studies. In this regard, we assessed risk factors promoting EVD associated infections and propose a modified practice-oriented definition of EVD associated infections.Methods: We performed a retrospective, single-center study on patients who were treated with an EVD, at the neurosurgical intensive care unit (ICU) at a tertiary center between 2008 and 2019. Based on microbiological findings and laboratory results, patients were assigned into an infection and a non-infection group. Patient characteristics and potential risk factors were compared between the two groups (p < 0.05). Receiver operating characteristics (ROC) for significant clinical, serum laboratory and cerebrospinal fluid (CSF) parameters were calculated.Results: In total, 396 patients treated with an EVD were included into the study with a mean age of 54.3 (range: 18–89) years. EVD associated infections were observed in 32 (8.1%) patients. EVD insertion at another hospital (OR 3.86), and an increased CSF sampling frequency of more than every third day (OR 12.91) were detected as major risk factors for an EVD associated infection. The indication for EVD insertion, surgeon's experience, the setting of EVD insertion (ICU vs. operating room) and the operating time did not show any significant differences between the two groups. Furthermore, ROC analysis showed that clinical, serum laboratory and CSF parameters did not provide specific prediction of EVD associated infections (specificity 44.4%). This explains the high overtreatment rate in our cohort with the majority of our patients who received intrathecal vancomycin (63.3%), having either negative microbiological results (n = 12) or were defined as contaminations (n = 7).Conclusions: Since clinical parameters and blood analyzes are not very predictive to detect EVD associated infections in neurosurgical patients, sequential but not too frequent microbiological and laboratory analysis of CSF are still necessary. Furthermore, we propose a uniform classification for EVD associated infections to allow comparability between studies and to sensitize the treating physician in determining the right treatment.